TransAlta (TAC)
(Delayed Data from NYSE)
$6.60 USD
-0.03 (-0.45%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $6.60 0.00 (0.00%) 7:28 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.60 USD
-0.03 (-0.45%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $6.60 0.00 (0.00%) 7:28 PM ET
2-Buy of 5 2
A Value B Growth B Momentum A VGM
Zacks News
5 Electric Power Stocks to Watch As COVID-Led Weakness Subsides
by Jewel Saha
Demand for electricity in the United States is rising from the lows touched during the pandemic. Utilities like NEE, DTE, EIX, CNP and TAC are poised to benefit from investments and focus on increasing electricity generation from clean sources.
TransAlta (TAC) is Overbought: Is A Drop Coming?
by Zacks Equity Research
TransAlta Corporation (TAC) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
TransAlta (TAC) Ups Dividend by 6%, Sells 303 MW of Clean Assets
by Zacks Equity Research
TransAlta Corporation (TAC) continues to work on its Clean Energy Investment Plan and decided to sell assets worth $439 million which will assist in meeting its objective laid out in the plan.
Should Value Investors Buy TransAlta (TAC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Stocks to Buy as Utilities Brave Coronavirus Bloodbath
by Shuvra Shankar Dey
Utilities are a good option now as their products are in constant demand irrespective of the current market volatility.
AES Corp. (AES) Looks Good: Stock Adds 8% in Session
by Zacks Equity Research
AES Corp. (AES) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
5 of the Best Coronavirus-Proof Stocks to Invest In Now
by Sreoshi Bera
With coronavirus cases on the rise, lack of labor and supply chain disruption are impacting businesses worldwide. However, certain industries could offer healthy returns on investment.
Company News for Mar 5, 2020
by Zacks Equity Research
Companies In The News Are: SPLK, CPB, TAC, JW.A.
Emerson to Support TransAlta in CTG Conversion Projects
by Zacks Equity Research
Emerson (EMR) will assist TransAlta in implementing CTG conversion projects at its Keephills and Sundance power plants.
TransAlta Inks Deal to Develop 40MW Cogeneration Facility
by Zacks Equity Research
TransAlta's (TAC) agreement with SemGroup ensures long-term EBITDA.
AES Corp (AES) to Develop Son My 2 Power Plant in Vietnam
by Zacks Equity Research
AES Corp (AES) signs 20-year contract agreement with the Vietnam Government.
TransAlta (TAC) Announces New Clean Energy Investment Plan
by Zacks Equity Research
TransAlta (TAC) intends to invest $2 billion to support clean energy.
TransAlta (TAC) Is Up 8.52% in One Week: What You Should Know
by Zacks Equity Research
Does TransAlta (TAC) have what it takes to be a top stock pick for momentum investors? Let's find out.
TransAlta (TAC) to Get $750M Aid to Meet Clean Energy Goal
by Zacks Equity Research
TransAlta (TAC) is set to get $750-million financial assistance from Brookfield Renewable to pursue its 100% clean energy goal.
Will TransAlta Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in TransAlta.
Moving Average Crossover Alert: TransAlta
by Zacks Equity Research
TransAlta Corporation (TAC) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Buy 5 Low-Beta Stocks as US-China Trade Tensions Escalate
by Nalak Das
Trump administration is deeply concerned about China's drive to unseat the United States as the primary developer and supplier of products in the fields of high-tech digital industries.
TransAlta (TAC) Takes a Step toward Clean Energy Transition
by Zacks Equity Research
TransAlta's (TAC) clean energy transition is expected to lower the marginal and operational costs of the company that hurt performance in the prior quarters of 2017.
CenterPoint Hits 52-Week High Backed by Customer Addition
by Zacks Equity Research
CenterPoint Energy Inc. (CNP) hit a new 52-week high of $28.24 on Apr 17.
Southern Company (SO) Announces Dividend Hike, Shares Up
by Zacks Equity Research
The Southern Company (SO) recently delivered pleasant news to investors. The company announced a hike in annual dividend by 8 cents to $2.32 per share.
NiSource (NI) Unit Files for Rate Hike to Recoup Investment
by Zacks Equity Research
NiSource Inc. (NI) announced that its unit Columbia Gas of Maryland, Inc. has filed for a rate hike with the Maryland Public Service Commission, asking for an annual revenue increase of $6 million.
Top Ranked Momentum Stocks to Buy for January 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 20th:
Should TransAlta (TAC) Be On Your Radar Now?
by Zacks Equity Research
One company that looks well positioned for a solid gain, but has been overlooked by investors lately, is TransAlta Corporation (TAC).
Company News for November 28, 2016
by Zacks Equity Research
Companies in the News are: JNJ,TAC,CTRP,NAVB,CAH